American Conference Institute (ACI) is hosting its 4th Annual Summit on Life Sciences IP Due Diligence on November 9-10, 2020. The virtual conference is devoted to providing life sciences/legal professionals with expert strategies for assessing, valuing and commercializing IP assets when conducting strategic IP due diligence. On November 9, GT Shareholder David Dykeman (BOS) will moderate the session, "Unique IP Due Diligence Considerations for Medical Devices, MedTech, and Artificial Intelligence." This session will address the unique considerations that companies face when approaching IP due diligence projects involving medical devices and inventions based on AI.